The comparison of Immune response to Third booster dose with of Vaxzevria or Comirnaty COVID-19 vaccine in healthcare workers after receiving two doses of CoronaVac

Background: The COVID-19 outbreak has significantly impacted public health, with vaccine effectiveness being crucial for control. The efficacy of heterologous prime-boost vaccines remains unclear. This study compared Vaxzevria and Comirnaty as booster doses given 90 days after two CoronaVac doses. M...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Auchara Tangsathapornpong, Sudatip Kositamongkol, Pornpimon Angkasekwinai, Peera Jaru-ampornpan, Pornumpa Bunjoungmanee, Prapasri Kulalert, Patcharaporn Punyashthira, Sira Nanthapisal
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2026-06-01
Reeks:	Vaccine: X
Onderwerpen:	COVID-19 Heterologous vaccination Immunogenicity
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2590136226000306
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!